Importantly, this study has effectively identified MG‐derived VDBP as a pivotal mediator in the interplay between microglia and neurons via its interaction with the neuronal receptor megalin and intricate downstream impacts on neuronal functions, thus offering a promising therapeutic target for MDD. The gene discussed is LRP2; the disease is major depressive disorder.